Endocytoscopic intramucosal capillary network changes and crypt architecture abnormalities can predict relapse in patients with an ulcerative colitis Mayo endoscopic score of 1

被引:20
|
作者
Maeda, Yasuharu [1 ]
Kudo, Shin-ei [1 ]
Ogata, Noriyuki [1 ]
Mori, Yuichi [1 ]
Misawa, Masashi [1 ]
Homma, Mayumi [2 ]
Nemoto, Tetsuo [2 ]
Ogawa, Masataka [1 ]
Sasanuma, Seiko [1 ]
Sato, Yuta [1 ]
Kataoka, Shinichi [1 ]
Kouyama, Yuta [1 ]
Sakurai, Tatsuya [1 ]
Igarashi, Kenta [1 ]
Ogawa, Yushi [1 ]
Kato, Kazuki [1 ]
Ichimasa, Katsuro [1 ]
Nakamura, Hiroki [1 ]
Kudo, Toyoki [1 ]
Hayashi, Takemasa [1 ]
Wakamura, Kunihiko [1 ]
Baba, Toshiyuki [1 ]
Inoue, Haruhiro [3 ]
Ohtsuka, Kazuo [4 ]
机构
[1] Showa Univ, Digest Dis Ctr, Northern Yokohama Hosp, 35-1 Tuzuki, Yokohama, Kanagawa 2248503, Japan
[2] Showa Univ, Dept Diagnost Pathol, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan
[3] Showa Univ, Digest Dis Ctr, Koto Toyosu Hosp, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Endoscopy Dept, Tokyo, Japan
关键词
biopsy; capillaries; endoscopy; histological; mucosa; INFLAMMATORY BOWEL DISEASES; BAND IMAGING EFFICIENCY; CLINICAL-USEFULNESS; COLORECTAL LESIONS; COLONOSCOPY; RISK; CLASSIFICATION; REMISSION; DIAGNOSIS;
D O I
10.1111/den.13655
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives Recent studies have suggested the necessity of therapeutic intervention for patients with ulcerative colitis at high risk of clinical relapse with a Mayo endoscopic score (MES) of 1. The aim of this retrospective cohort study was to demonstrate the impact of intramucosal capillary network changes and crypt architecture abnormalities to stratify the risk of relapse in patients with an MES of 1. Methods All included patients had an MES of <= 1 and confirmed sustained clinical remission between October 2016 and April 2019. We classified patients with an MES of 1 as "intramucosal capillary/crypt (ICC)-active" or "ICC-inactive" using endocytoscopic evaluation. We followed patients until October 2019 or until relapse; the main outcome measure was the difference in clinical relapse-free rates between ICC-active and ICC-inactive patients with an MES of 1. Results We included 224 patients and analyzed data for 218 (82 ICC-active and 54 ICC-active with an MES of 1 and 82 with an MES of 0). During follow-up, among the patients with an MES of 1, 30.5% (95% confidence interval 20.8-41.6; 25/82) of the patients relapsed in the ICC-active group and 5.6% (95% confidence interval 1.2-15.4; 3/54) of the patients relapsed in the ICC-inactive group. The ICC-inactive group had a significantly higher clinical relapse-free rate compared with the ICC-active group (P < 0.01). Conclusions In vivointramucosal capillary network and crypt architecture patterns stratified the risk of clinical relapse in patients with an MES of 1 (UMIN 000032580; UMIN 000036359).
引用
收藏
页码:1082 / 1091
页数:10
相关论文
共 12 条
  • [1] Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1
    Fukuda, Tomohiro
    Naganuma, Makoto
    Sugimoto, Shinya
    Ono, Keiko
    Nanki, Kosaku
    Mizuno, Shinta
    Kimura, Kayoko
    Mutaguchi, Makoto
    Nakazato, Yoshihiro
    Takabayashi, Kaoru
    Inoue, Nagamu
    Ogata, Haruhiko
    Iwao, Yasushi
    Kanai, Takanori
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (04) : 782 - 788
  • [2] Efficacy of therapeutic intervention for ulcerative colitis patients with the Mayo Endoscopic Score of 1
    Fukuda, T.
    Naganuma, M.
    Sugimoto, S.
    Ono, K.
    Nanki, K.
    Mizuno, S.
    Kimura, K.
    Mutaguchi, M.
    Takabayashi, K.
    Inoue, N.
    Ogata, H.
    Iwao, Y.
    Kanai, T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S470 - S470
  • [3] FAECAL CALPROTECTIN TO PREDICT THE RISK OF RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION AND ENDOSCOPIC MAYO SCORE 0 OR 1: RESULTS OF THE CALPRODICT-UC STUDY
    Buisson, Anthony
    Carpentier, Constantin
    Minet-Quinard, Regine
    Pereira, Bruno
    GASTROENTEROLOGY, 2023, 164 (06) : S884 - S884
  • [4] Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission
    George, Lauren A.
    Feldman, Harris T.
    Alizadeh, Madeline
    Abutaleb, Ameer
    Zullow, Samantha
    Hine, Ashley
    Stashek, Kristen
    Sarkar, Suparna
    Sun, Katherine
    Hudesman, David
    Axelrad, Jordan
    Cross, Raymond K.
    CROHNS & COLITIS 360, 2023, 5 (04)
  • [5] COMPARISON OF RELAPSE RATES IN ULCERATIVE COLITIS PATIENTS WITH MAYO ENDOSCOPIC SCORE OF 0 OR 1: SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
    Aggarwal, S.
    Topaloglu, O.
    Kumar, S.
    Bela, A.
    VALUE IN HEALTH, 2022, 25 (12) : S19 - S19
  • [6] Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
    Viscido, Angelo
    Valvano, Marco
    Stefanelli, Gianpiero
    Capannolo, Annalisa
    Castellini, Chiara
    Onori, Eugenia
    Ciccone, Antonio
    Vernia, Filippo
    Latella, Giovanni
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [7] Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
    Angelo Viscido
    Marco Valvano
    Gianpiero Stefanelli
    Annalisa Capannolo
    Chiara Castellini
    Eugenia Onori
    Antonio Ciccone
    Filippo Vernia
    Giovanni Latella
    BMC Gastroenterology, 22
  • [8] Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing
    Gonzalez-Partida, Irene
    Martinez-Lozano, Helena
    Gonzalez-Lois, Carmen
    Peligros, Isabel
    Sanchez-Yuste, Rosario
    Salas, Isabel
    Matallana, Virginia
    Bighelli, Federico
    Calvo, Marta
    Marin-Jimenez, Ignacio
    Salas, Clara
    Vera, Maria I.
    Menchen, Luis
    Gonzalez-Lama, Yago
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E796 - E802
  • [9] Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing
    Gonzalez-Partida, Irene
    Martinez-Lozano, Helena
    Gonzalez-Lois, Carmen
    Peligros, Isabel
    Sanchez-Yuste, Rosario
    Salas, Isabel
    Matallana, Virginia
    Bighelli, Federico
    Calvo, Marta
    Marin-Jimenez, Ignacio
    Salas, Clara
    Vera, Maria I.
    Menchen, Luis
    Gonzalez-Lama, Yago
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E796 - E802
  • [10] Expression profile of serum LncRNAs MALAT-1 and CCAT-1 and their correlation with Mayo severity score in ulcerative colitis patients can diagnose and predict the prognosis of the disease
    Ali, Marwa A.
    Shaker, Olfat G.
    Ali, El Shimaa Gomaa
    Ezzat, Eman M.
    Khalifa, Abeer A.
    Hassan, Essam A.
    Habib, Marwa A.
    Ahmed, Heba Mostafa
    Dawood, Asmaa F. A.
    Mohamed, Esam Ali
    NON-CODING RNA RESEARCH, 2024, 9 (02): : 318 - 329